PMHNP Certification Exam
Original Practice Question Bank
300 Original Multiple-Choice Questions with Answer Keys & Clinical
Rationales
Covering Assessment, Psychopathology, Psychopharmacology, Therapeutic
Modalities, Legal/Ethical Practice, and Special Populations
About this resource: This is an original, independently authored study resource created to help Psychiatric-Mental
Health Nurse Practitioner (PMHNP) students and candidates review core clinical content relevant to certification exam
preparation. All questions, answer choices, and rationales in this document were independently written based on
established clinical references, DSM-5-TR diagnostic criteria, and standard psychopharmacology principles. This
resource is not affiliated with, endorsed by, or derived from any specific commercial exam preparation product, and it is
not a reproduction of any copyrighted or proprietary exam content. It is intended solely as a supplemental self-study and
self-assessment tool and does not replace formal PMHNP education, clinical training, official certification exam
blueprints (ANCC or AANP), or clinical judgment. Always verify current prescribing information, dosing, and guidelines
against up-to-date primary sources (e.g., current package inserts, professional society guidelines) prior to clinical
application, as clinical practice standards evolve over time.
Page 1
,Table of Contents
1. Section 1: Neurobiological & Genetic Foundations of Psychiatric Illness 20 questions
2. Section 2: Psychiatric Assessment & Diagnostic Interviewing 20 questions
3. Section 3: Depressive Disorders 19 questions
4. Section 4: Bipolar and Related Disorders 19 questions
5. Section 5: Anxiety, Obsessive-Compulsive, and Trauma-Related Disorders 19 questions
6. Section 6: Schizophrenia Spectrum and Other Psychotic Disorders 19 questions
7. Section 7: Substance-Related and Addictive Disorders 19 questions
8. Section 8: Personality Disorders 19 questions
9. Section 9: Neurodevelopmental Disorders and Child/Adolescent Psychiatry 18 questions
10. Section 10: Neurocognitive Disorders and Geriatric Psychiatric Care 18 questions
11. Section 11: Psychopharmacology I — Antidepressants and Anxiolytics 19 questions
12. Section 12: Psychopharmacology II — Antipsychotics and Mood Stabilizers 18 questions
13. Section 13: Therapeutic Modalities and Psychotherapy Foundations 15 questions
14. Section 14: Legal, Ethical, and Professional Practice Issues 15 questions
15. Section 15: Special Populations — Pregnancy/Lactation, Perinatal, and Cross-Cultural
15 questions
Considerations
How to use this question bank: Each section presents its full set of questions first, so you can complete them under
timed, exam-like conditions before checking your work. The Answer Key & Rationales for that section immediately
follow. Consider covering the answer key section with a blank sheet of paper while attempting the questions.
Page 2
,1. Section 1: Neurobiological & Genetic Foundations of
Psychiatric Illness
This section covers neurotransmitter systems, neuroanatomy, genetics, and neuroendocrine principles that
underlie psychiatric diagnosis and treatment selection.
1. Which neurotransmitter is primarily synthesized from tryptophan and is most strongly
implicated in mood regulation, sleep, and appetite?
A. Dopamine
B. Serotonin
C. Glutamate
D. Acetylcholine
2. The mesolimbic dopamine pathway, when dysregulated with excess dopaminergic activity, is
most closely associated with which symptom cluster?
A. Negative symptoms of schizophrenia
B. Positive symptoms of psychosis (hallucinations, delusions)
C. Extrapyramidal symptoms
D. Cognitive symptoms of schizophrenia
3. A patient's blunted affect, avolition, and social withdrawal in schizophrenia are best
explained by dysfunction in which dopamine pathway?
A. Mesolimbic pathway
B. Mesocortical pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
4. Which brain structure, when it shows reduced volume on neuroimaging, is most consistently
associated with major depressive disorder and PTSD?
A. Hippocampus
B. Cerebellum
C. Occipital lobe
D. Corpus callosum
5. A patient carrying two short (s) alleles of the serotonin transporter gene promoter
(5-HTTLPR) polymorphism, when exposed to significant early-life stress, has increased risk for
which outcome?
A. Decreased risk of depression regardless of stress exposure
B. Increased vulnerability to depression following stressful life events
C. Immunity to SSRI side effects
D. Enhanced resilience to trauma
Page 3
, 6. Which neurotransmitter is the primary excitatory neurotransmitter in the CNS and is central
to the glutamate hypothesis of schizophrenia (NMDA receptor hypofunction)?
A. GABA
B. Norepinephrine
C. Glutamate
D. Histamine
7. GABA is the primary inhibitory neurotransmitter in the CNS. Benzodiazepines exert their
anxiolytic effect by:
A. Blocking GABA-A receptors
B. Enhancing GABA-A receptor chloride channel opening frequency
C. Increasing glutamate release
D. Inhibiting GABA reuptake directly
8. The HPA axis dysregulation seen in major depressive disorder is classically demonstrated by
which finding on the dexamethasone suppression test (DST)?
A. Normal cortisol suppression
B. Failure to suppress cortisol
C. Complete absence of cortisol
D. Suppressed ACTH but elevated cortisol
9. Which brain region's dysfunction is most associated with impaired fear extinction and
hypervigilance in PTSD?
A. Amygdala (hyperactivity) and ventromedial prefrontal cortex (hypoactivity)
B. Cerebellum hyperactivity
C. Basal ganglia atrophy
D. Occipital cortex hyperactivity
10. A first-degree relative of a person with schizophrenia has approximately what lifetime risk of
developing schizophrenia, compared to the general population risk of about 1%?
A. About 2%, barely above general population
B. About 10%
C. About 50%
D. About 90%
11. Which neurotransmitter's excess in the synaptic cleft, from reuptake inhibition, is most
responsible for the activating and anxiogenic side effects sometimes seen early in SNRI
treatment?
A. Serotonin only
B. Norepinephrine
C. Dopamine only
D. GABA
Page 4
Original Practice Question Bank
300 Original Multiple-Choice Questions with Answer Keys & Clinical
Rationales
Covering Assessment, Psychopathology, Psychopharmacology, Therapeutic
Modalities, Legal/Ethical Practice, and Special Populations
About this resource: This is an original, independently authored study resource created to help Psychiatric-Mental
Health Nurse Practitioner (PMHNP) students and candidates review core clinical content relevant to certification exam
preparation. All questions, answer choices, and rationales in this document were independently written based on
established clinical references, DSM-5-TR diagnostic criteria, and standard psychopharmacology principles. This
resource is not affiliated with, endorsed by, or derived from any specific commercial exam preparation product, and it is
not a reproduction of any copyrighted or proprietary exam content. It is intended solely as a supplemental self-study and
self-assessment tool and does not replace formal PMHNP education, clinical training, official certification exam
blueprints (ANCC or AANP), or clinical judgment. Always verify current prescribing information, dosing, and guidelines
against up-to-date primary sources (e.g., current package inserts, professional society guidelines) prior to clinical
application, as clinical practice standards evolve over time.
Page 1
,Table of Contents
1. Section 1: Neurobiological & Genetic Foundations of Psychiatric Illness 20 questions
2. Section 2: Psychiatric Assessment & Diagnostic Interviewing 20 questions
3. Section 3: Depressive Disorders 19 questions
4. Section 4: Bipolar and Related Disorders 19 questions
5. Section 5: Anxiety, Obsessive-Compulsive, and Trauma-Related Disorders 19 questions
6. Section 6: Schizophrenia Spectrum and Other Psychotic Disorders 19 questions
7. Section 7: Substance-Related and Addictive Disorders 19 questions
8. Section 8: Personality Disorders 19 questions
9. Section 9: Neurodevelopmental Disorders and Child/Adolescent Psychiatry 18 questions
10. Section 10: Neurocognitive Disorders and Geriatric Psychiatric Care 18 questions
11. Section 11: Psychopharmacology I — Antidepressants and Anxiolytics 19 questions
12. Section 12: Psychopharmacology II — Antipsychotics and Mood Stabilizers 18 questions
13. Section 13: Therapeutic Modalities and Psychotherapy Foundations 15 questions
14. Section 14: Legal, Ethical, and Professional Practice Issues 15 questions
15. Section 15: Special Populations — Pregnancy/Lactation, Perinatal, and Cross-Cultural
15 questions
Considerations
How to use this question bank: Each section presents its full set of questions first, so you can complete them under
timed, exam-like conditions before checking your work. The Answer Key & Rationales for that section immediately
follow. Consider covering the answer key section with a blank sheet of paper while attempting the questions.
Page 2
,1. Section 1: Neurobiological & Genetic Foundations of
Psychiatric Illness
This section covers neurotransmitter systems, neuroanatomy, genetics, and neuroendocrine principles that
underlie psychiatric diagnosis and treatment selection.
1. Which neurotransmitter is primarily synthesized from tryptophan and is most strongly
implicated in mood regulation, sleep, and appetite?
A. Dopamine
B. Serotonin
C. Glutamate
D. Acetylcholine
2. The mesolimbic dopamine pathway, when dysregulated with excess dopaminergic activity, is
most closely associated with which symptom cluster?
A. Negative symptoms of schizophrenia
B. Positive symptoms of psychosis (hallucinations, delusions)
C. Extrapyramidal symptoms
D. Cognitive symptoms of schizophrenia
3. A patient's blunted affect, avolition, and social withdrawal in schizophrenia are best
explained by dysfunction in which dopamine pathway?
A. Mesolimbic pathway
B. Mesocortical pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
4. Which brain structure, when it shows reduced volume on neuroimaging, is most consistently
associated with major depressive disorder and PTSD?
A. Hippocampus
B. Cerebellum
C. Occipital lobe
D. Corpus callosum
5. A patient carrying two short (s) alleles of the serotonin transporter gene promoter
(5-HTTLPR) polymorphism, when exposed to significant early-life stress, has increased risk for
which outcome?
A. Decreased risk of depression regardless of stress exposure
B. Increased vulnerability to depression following stressful life events
C. Immunity to SSRI side effects
D. Enhanced resilience to trauma
Page 3
, 6. Which neurotransmitter is the primary excitatory neurotransmitter in the CNS and is central
to the glutamate hypothesis of schizophrenia (NMDA receptor hypofunction)?
A. GABA
B. Norepinephrine
C. Glutamate
D. Histamine
7. GABA is the primary inhibitory neurotransmitter in the CNS. Benzodiazepines exert their
anxiolytic effect by:
A. Blocking GABA-A receptors
B. Enhancing GABA-A receptor chloride channel opening frequency
C. Increasing glutamate release
D. Inhibiting GABA reuptake directly
8. The HPA axis dysregulation seen in major depressive disorder is classically demonstrated by
which finding on the dexamethasone suppression test (DST)?
A. Normal cortisol suppression
B. Failure to suppress cortisol
C. Complete absence of cortisol
D. Suppressed ACTH but elevated cortisol
9. Which brain region's dysfunction is most associated with impaired fear extinction and
hypervigilance in PTSD?
A. Amygdala (hyperactivity) and ventromedial prefrontal cortex (hypoactivity)
B. Cerebellum hyperactivity
C. Basal ganglia atrophy
D. Occipital cortex hyperactivity
10. A first-degree relative of a person with schizophrenia has approximately what lifetime risk of
developing schizophrenia, compared to the general population risk of about 1%?
A. About 2%, barely above general population
B. About 10%
C. About 50%
D. About 90%
11. Which neurotransmitter's excess in the synaptic cleft, from reuptake inhibition, is most
responsible for the activating and anxiogenic side effects sometimes seen early in SNRI
treatment?
A. Serotonin only
B. Norepinephrine
C. Dopamine only
D. GABA
Page 4
